Cysteamine for Asthma

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 18, 2019

Primary Completion Date

February 10, 2021

Study Completion Date

February 10, 2021

Conditions
Asthma
Interventions
DRUG

Cysteamine Bitartrate

Cysteamine bitartrate administered four times per day (QID) for 8 weeks. 125mg tablet QID.

DRUG

Placebo Oral Tablet

Placebo administered for 8 weeks. 125mg tablet QID.

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT03883984 - Cysteamine for Asthma | Biotech Hunter | Biotech Hunter